Cerebral Tranquility Nighttime Gummy with CBN
-
Product Info
CBN + Melatonin Gummies
Advanced Sleep & Migraine Support
Made with pure and precisely dosed cannabinol (CBN) using state-of-the-art technology and melatonin, our naturally-flavored watermelon CBN sleep gummies harness the power of hemp to promote relaxation and ease tension. This synergistic combination works to:
- Calm overactive nerves*
- Reduce inflammation*
- Quiet pain signals*
- Soothe the mind*
- Guide your body into restorative sleep*
The special combination of CBN + melatonin leverages their complementary therapeutic effects to deliver powerful support for:- Insomnia*
- Chronic Pain*
- Migraine headaches*
✓ 10mg CBN + 5mg Melatonin per Gummy (NO THC!) ✓ Legal in ALL 50 States ✓ 100% Naturally Flavored Watermelon Taste ✓ No Artificial Colors or Preservatives ✓ Vegan, Non-GMO, Gluten-Free ✓ Made in an FDA-Registered Facility Under cGMP Guidelines ✓ Lab Tested for Quality and Compliance* These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease. Always consult with your healthcare professional before starting any new regimen.
Cerebral Tranquility FAQ
Fri, Jul 11, 25
Migraine and Depression: Shared Brain Mechanisms
Learn why migraine and depression are linked through shared brain pathways. 2025 research reveals genetic connections and dual-action treatments for both.
Mon, Jul 07, 25
Chronic Pain and Brain Gene Expression
New study proves chronic pain is biological. Brain immune cells drive pain, offering hope for targeted migraine and chronic pain treatments.
Sat, Jul 05, 25
Migraine & White Matter Hyperintensities
Migraine and white matter hyperintensities: Recent studies show NO association. Large-scale 2023-2025 research contradicts older findings. Important clinical implications explained.
Wed, Jul 02, 25
Endocannabinoid System Genetics Breakthrough in Medication Overuse Headache
Breakthrough genetics study reveals FAAH gene changes in medication overuse headache. Endocannabinoid DNA differences could transform diagnosis and treatment.